lifestyle.massnews.com

Author: FLAGSHIP PIONEERING

Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors

April 23, 2026
Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology

April 21, 2026
Ampersand Biomedicines Presents Preclinical Data on AMP-220, a Gut-Targeted IL-22 AND-Body™ Therapeutic, at AAI 2026

April 20, 2026
Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug Discovery and Life Sciences Innovation

April 1, 2026
Flagship Pioneering Appoints Eric Topol as Academic Advisor to Advance Preemptive Health and Medicine Initiative

March 17, 2026
Etiome Announces Publication of Patient Modeling for Early Disease Detection in JAMIA Open

February 23, 2026
Repertoire® Immune Medicines Announces Strategic Collaboration with Lilly to Develop Tolerizing Therapies for Autoimmune Diseases

January 29, 2026
Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome

January 8, 2026
Etiome Strengthens Leadership Team with Appointment of Jean Lachowicz as Chief Scientific Officer

December 22, 2025
Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer

December 22, 2025